Discovery of a bicyclo[4.3.0]nonane derivative DS88790512 as a potent, selective, and orally bioavailable blocker of transient receptor potential canonical 6 (TRPC6)

Bioorganic & Medicinal Chemistry Letters
2018.0

Abstract

In this study, we aimed to synthesize a novel blocker of transient receptor potential canonical 6 (TRPC6). The sp2 carbon atoms of the aminoindane skeleton of the known inhibitor were replaced with sp3 carbon atoms to increase the molecular complexity, measured by fraction sp3 (Fsp3). The representative compound, a bicyclo[4.3.0]nonane derivative DS88790512, inhibited TRPC6 with an IC50 value of 11 nM. Notably, DS88790512 exhibited excellent selectivity against hERG and hNaV1.5 channels, and was identified as an orally bioavailable compound.

Knowledge Graph

Similar Paper

Discovery of a bicyclo[4.3.0]nonane derivative DS88790512 as a potent, selective, and orally bioavailable blocker of transient receptor potential canonical 6 (TRPC6)
Bioorganic & Medicinal Chemistry Letters 2018.0
Synthesis and biological evaluation of 1,4-diazepane derivatives as T-type calcium channel blockers
Bioorganic & Medicinal Chemistry Letters 2010.0
Synthesis and biological evaluation of 1-(2-hydroxy-3-phenyloxypropyl)piperazine derivatives as T-type calcium channel blockers
Bioorganic & Medicinal Chemistry Letters 2013.0
A novel [5.2.1]bicyclic amine is a potent analgesic without µ opioid activity
Bioorganic & Medicinal Chemistry Letters 2021.0
Natural product inspired optimization of a selective TRPV6 calcium channel inhibitor
RSC Medicinal Chemistry 2020.0
Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1′H-spiro[chromene-2,4′-piperidine]-1′-carboxamides as TRPM8 antagonists
Bioorganic & Medicinal Chemistry 2013.0
Synthesis of resveratrol derivatives as new analgesic drugs through desensitization of the TRPA1 receptor
Bioorganic & Medicinal Chemistry Letters 2017.0
Synthesis and SAR of 4-aminocyclopentapyrrolidines as N-type Ca2+ channel blockers with analgesic activity
Bioorganic & Medicinal Chemistry 2012.0
Discovery of conolidine derivative DS39201083 as a potent novel analgesic without mu opioid agonist activity
Bioorganic & Medicinal Chemistry Letters 2019.0
Discovery of a novel bicyclic compound, DS54360155, as an orally potent analgesic without mu-opioid receptor agonist activity
Bioorganic & Medicinal Chemistry Letters 2019.0